Federal Register / Vol. 86, No. 11 / Tuesday, January 19, 2021 / Notices 5249 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1153] 

Certain Bone Cements, Components 

Thereof and Products Containing the 

Same; Notice of Commission 

Determination Finding No Violation of 

Section 337; Termination of the 

Investigation 

AGENCY: International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined to affirm in part, reverse in 

part, and vacate in part the final initial 

determination’s (‘‘ID’’) finding that no 

violation of section 337 has occurred. 

The investigation is terminated. 

FOR FURTHER INFORMATION CONTACT: 

Ronald A. Traud, Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3427. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on April 10, 2019, based on a complaint 

filed by Heraeus Medical LLC of 

Yardley, Pennsylvania, and Heraeus 

Medical GmbH of Wehrheim, Germany 

(collectively, ‘‘Complainants’’). 84 FR 

14394–95 (Apr. 10, 2019). The 

complaint alleges a violation of section 

337 of the Tariff Act of 1930, as 

amended, by reason of misappropriation 

of trade secrets, the threat or effect of 

which is to destroy or substantially 

injure an industry in the United States 

or to prevent the establishment of such 

an industry. The complaint named the 

following respondents: Zimmer Biomet 

Holdings, Inc. of Warsaw, Indiana; 

Biomet, Inc. of Warsaw, Indiana; 

Zimmer Orthopaedic Surgical Products, 

Inc. of Dover, Ohio; Zimmer Surgical, 

Inc. of Dover, Ohio; Biomet France 

S.A.R.L. of Valence, France; Biomet 

Deutschland GmbH of Berlin, Germany; 

Zimmer Biomet Deutschland GmbH of 

Freiburg im Breisgau, Germany; Biomet 

Europe B.V. of Dordrecht, Netherlands; 

Biomet Global Supply Chain Center B.V. 

of Dordrecht, Netherlands; Zimmer 

Biomet Nederland B.V. of Dordrecht, 

Netherlands; Biomet Orthopedics, LLC 

of Warsaw, Indiana; and Biomet 

Orthopaedics Switzerland GmbH of 

Dietikon, Switzerland. The 

Commission’s Office of Unfair Import 

Investigations (‘‘OUII’’) also was named 

as a party. 

The investigation has terminated as to 

respondents Zimmer Orthopaedic 

Surgical Products, Inc. and Biomet 

Europe B.V., Order No. 10 (May 23, 

2019), unreviewed, Notice (June 14, 

2019), and as to certain accused 

products, Order No. 30 (Nov. 24, 2019), 

unreviewed, Notice (Dec. 10, 2019). 

Also, the first amended complaint and 

notice of investigation were amended to 

add three entities as respondents: 

Zimmer US, Inc.; Zimmer, GmbH; and 

Biomet Manufacturing, LLC. Order No. 

18 (June 26, 2019), unreviewed, 84 FR 

35884–85 (July 25, 2019). The remaining 

respondents are referred to collectively 

herein as ‘‘Zimmer Biomet.’’ 

On May 6, 2020, the presiding 

administrative law judge (‘‘ALJ’’) issued 

the final ID, which found that Zimmer 

Biomet did not violate section 337. On 

May 18, 2020, the parties filed petitions 

for review of the final ID. 

On July 13, 2020, the Commission 

determined to review in part the final ID 

and requested briefing from the parties 

on the issues under review. In 

particular, the Commission determined 

to review the following: (1) The ALJ’s 

findings and conclusions as to TS 1–35 

and 121–23; and (2) the ALJ’s domestic 

industry findings, including whether 

there has been a substantial injury to the 

alleged domestic industry. The 

Commission also sought briefing from 

the parties, interested government 

agencies, and any other interested 

parties on remedy, bonding, and the 

public interest. 

Having examined the record of this 

investigation, including the final ID, the 

petitions for review, the responses 

thereto, and the written submissions in 

response to the Commission’s request 

for briefing, the Commission finds that 

no violation of section 337 has occurred. 

Specifically, the Commission finds that 

the Complainants did not establish that 

an industry in the United States exists 

as required by section 337(a)(1)(A)(i) 

and therefore did not establish injury to 

a domestic industry. The investigation 

is hereby terminated. 

The Commission vote for this 

determination took place on January 12, 

2021. 

The authority for the Commission’s 

determination is contained in section 

337 of the Tariff Act of 1930, as 

amended (19 U.S.C. 1337), and in Part 

210 of the Commission’s Rules of 

Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: January 12, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–00996 Filed 1–15–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1200] 

Certain Electronic Devices, Including 

Streaming Players, Televisions, Set 

Top Boxes, Remote Controllers, and 

Components Thereof; Notice of a 

Commission Determination Not To 

Review an Initial Determination 

Correcting the Notice of Investigation 

AGENCY: International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined not to review an initial 

determination (‘‘ID’’) (Order No. 33), 

granting the parties’ joint motion to 

amend the notice of institution of the 

investigation by clarifying that claims 2 

and 4–5 of U.S. Patent No. 10,593,196 

(‘‘the ’196 patent’’) are among the 

domestic industry claims but are not 

being asserted against any respondent 

for purposes of infringement. The notice 

of investigation is amended accordingly. 

FOR FURTHER INFORMATION CONTACT: Carl 

P. Bretscher, Esq., Office of the General 

Counsel, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–2382. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on May 22, 2020, based on a complaint 


khammond on DSKJM1Z7X2PROD with NOTICES